1. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, Mar-Apr 2016, 66(2): 115-132.
|
2. |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
3. |
Merkow RP, Bilimoria KY, Keswani RN, et al. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst, 2014, 106(7): dju133.
|
4. |
Nentwich MF, von Loga K, Reeh M, et al. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg, 2014, 18(2): 242-249.
|
5. |
Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: A retrospective analysis of 295 patients. Ann Surg, 2013, 257(6): 1032-1038.
|
6. |
Lee L, Ronellenfitsch U, Hofstetter WL, et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg, 2013, 217(2): 191-199.
|
7. |
Gertler R, Stein HJ, Schuster T, et al. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg, 2014, 259(1): 96-101.
|
8. |
Tanaka T, Matono S, Mori N, et al. T1 squamous cell carcinoma of the esophagus: Long-term outcomes and prognostic factors after esophagectomy. Ann Surg Oncol, 2014, 21(3): 932-938.
|
9. |
Dubecz A, Kern M, Solymosi N, et al. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg, 2015, 99(6): 1879-1885.
|
10. |
Zhang H, Tang P, Miao X, et al. Does tumor size improve the accuracy of prognostic prediction in patients with esophageal squamous cell carcinoma after surgical resection? Oncotarget, 2016, 7(41): 66623-66634.
|
11. |
Hsu WH, Hsu PK, Hsieh CC, et al. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg, 2009, 13(11): 1913-1920.
|
12. |
Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: An international study on the impact of extent of surgical resection. Ann Surg, 2008, 248(4): 549-556.
|
13. |
Hsu PK, Chien LI, Wang LC, et al. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg, 2017, 51(6): 1188-1194.
|
14. |
Kuge K, Murakami G, Mizobuchi S, et al. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg, 2003, 125(6): 1343-1349.
|
15. |
Mizutani M, Murakami G, Nawata S, et al. Anatomy of right recurrent nerve node: Why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat, 2006, 28(4): 333-338.
|
16. |
Bollschweiler E, Baldus SE, Schröder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy, 2006, 38(2): 149-156.
|
17. |
Endo M, Yoshino K, Kawano T, et al. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus, 2000, 13(2): 125-129.
|
18. |
Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2010. Esophagus, 2017, 14(3): 189-214.
|
19. |
Wang J, Zhu XN, Zhu LL, et al. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions. World J Gastroenterol, 2018, 24(26): 2878-2885.
|
20. |
Suzuki G, Yamazaki H, Aibe N, et al. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: Choice of new approach. Radiat Oncol, 2018, 13(1): 246.
|
21. |
Kawaguchi G, Sasamoto R, Abe E, et al. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiat Oncol, 2015, 10: 31.
|
22. |
Ikeda A, Hoshi N, Yoshizaki T, et al. Endoscopic submucosal dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion. Intern Med, 2015, 54(22): 2803-2813.
|